EJNMMI Research

Table 2 Comparison of patient clinical characteristics with TMTV

From: Prognostic value of baseline total metabolic tumour volume of ¹⁸F-FDG PET/CT imaging in patients with angioimmunoblastic T-cell lymphoma

Characteristics	No. of patients (n = 56)	TMTV
Characteristics	No. of patients (n = 56)	Low (n = 29)	High (n = 27)	P value
Sex, female/male	23/33	16/13	7/20	0.026
Age, ≤ 60/ > 60	20/36	13/16	7/20	0.140
B symptoms, no/yes	20/36	12/17	8/19	0.359
LDH, normal/elevated	14/42	10/19	4/23	0.089
ECOG-PS,0–1/2–5	43/13	27/2	16/11	0.003
PLT count, normal/declined	35/21	22/7	13/14	0.032
Albumin, normal/declined	15/41	9/20	6/21	0.457
β2-MG, normal/elevated	20/36	11/18	9/18	0.720
BMB, negative/positive	43/13	25/4	18/9	0.084
Ann Arbor stage II–III/IV	28/28	21/8	7/20	0.001
Extranodal sites > 1, no/yes	47/9	26/3	21/6	0.227
IPI,0–2/3–5	25/31	13/16	12/15	0.977
PIT,0–1/2–4	36/20	23/6	13/14	0.015

LDH, lactate dehydrogenase; ECOG-PS, Eastern Cooperative Oncology Group Performance Status; PLT, platelet; β2-MG, β2-microglobulin; BMB, bone marrow biopsy; IPI, international prognostic index; PIT, prognostic index for T-cell lymphoma

Back to article page